1. P436: TARGETED DELIVERY OF T22-PE24-H6 TO CXCR4 POSITIVE CELLS FOR ACUTE MYELOID LEUKEMIA TREATMENT. (23rd June 2022) Authors: Núñez Amela, Y.; Garcia-León, A.; Falgàs, A.; Serna, N.; Sánchez-García, L.; Garrido, A.; Sierra, J.; Gallardo, A.; Unzueta, U.; Vázquez, E.; Villaverde, A.; Mangues, R.; Casanova, I. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 336 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The fusogenic peptide HA2 impairs selectivity of CXCR4-targeted protein nanoparticles. Issue 33 (21st March 2017) Authors: Sánchez-García, L.; Serna, N.; Mattanovich, M.; Cazzanelli, P.; Sánchez-Chardi, A.; Conchillo-Solé, O.; Cortés, F.; Daura, X.; Unzueta, U.; Mangues, R.; Villaverde, A.; Vázquez, E. Journal: Chemical communications Issue: Volume 53:Issue 33(2017) Page Start: 4565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗